Open AccessEstimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis
Author(s) -
David R. Holtgrave
Publication year - 2002
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200211220-00020
Subject(s) - human immunodeficiency virus (hiv) , cost effectiveness , cost effectiveness analysis , medicine , cost–benefit analysis , environmental health , disease prevention , risk analysis (engineering) , immunology , political science , law
Scenario and cost-effectiveness analyses were used to estimate the effectiveness and efficiency of HIV prevention activities in the USA (1978-2000). Under four conservative scenarios on the course of HIV epidemic that might have occurred had there been no prevention efforts. we estimate that prevention activities averted 204,000-1,585,000 infections at a cost of between 49,700 US dollars and 6400 US dollars per infection prevented (less than the medical costs of treating a case of HIV disease).